109 related articles for article (PubMed ID: 20863716)
21. Differentiation of ruminant transmissible spongiform encephalopathy isolate types, including bovine spongiform encephalopathy and CH1641 scrapie.
Jacobs JG; Sauer M; van Keulen LJ; Tang Y; Bossers A; Langeveld JP
J Gen Virol; 2011 Jan; 92(Pt 1):222-32. PubMed ID: 20943889
[TBL] [Abstract][Full Text] [Related]
22. Investigations of prion and virus safety of a new liquid IVIG product.
Stucki M; Boschetti N; Schäfer W; Hostettler T; Käsermann F; Nowak T; Gröner A; Kempf C
Biologicals; 2008 Jul; 36(4):239-47. PubMed ID: 18337119
[TBL] [Abstract][Full Text] [Related]
23. Transmissible spongiform encephalopathy agent clearance by the immunoaffinity and anion-exchange chromatography steps of the ReFacto manufacturing process.
Booth J; Vicik S; Tannatt M; Gallo C; Kelley B
Haemophilia; 2007 Sep; 13(5):580-7. PubMed ID: 17880447
[TBL] [Abstract][Full Text] [Related]
24. Prion inactivation by the Maillard reaction.
Suyama K; Yoshioka M; Akagawa M; Murayama Y; Horii H; Takata M; Yokoyama T; Mohri S
Biochem Biophys Res Commun; 2007 Apr; 356(1):245-8. PubMed ID: 17336934
[TBL] [Abstract][Full Text] [Related]
25. Removal of prion infectivity by affinity ligand chromatography during OctaplasLG® manufacturing--results from animal bioassay studies.
Heger A; Bailey A; Neisser-Svae A; Ertl M; Römisch J; Svae TE
Vox Sang; 2012 May; 102(4):294-301. PubMed ID: 22070802
[TBL] [Abstract][Full Text] [Related]
26. Generation of genuine prion infectivity by serial PMCA.
Weber P; Giese A; Piening N; Mitteregger G; Thomzig A; Beekes M; Kretzschmar HA
Vet Microbiol; 2007 Aug; 123(4):346-57. PubMed ID: 17493773
[TBL] [Abstract][Full Text] [Related]
27. Pall leukotrap affinity prion-reduction filter removes exogenous infectious prions and endogenous infectivity from red cell concentrates.
Sowemimo-Coker SO; Pesci S; Andrade F; Kim A; Kascsak RB; Kascsak RJ; Meeker C; Carp R
Vox Sang; 2006 May; 90(4):265-75. PubMed ID: 16635068
[TBL] [Abstract][Full Text] [Related]
28. Identification of a second bovine amyloidotic spongiform encephalopathy: molecular similarities with sporadic Creutzfeldt-Jakob disease.
Casalone C; Zanusso G; Acutis P; Ferrari S; Capucci L; Tagliavini F; Monaco S; Caramelli M
Proc Natl Acad Sci U S A; 2004 Mar; 101(9):3065-70. PubMed ID: 14970340
[TBL] [Abstract][Full Text] [Related]
29. The prion/lipid hypothesis--further evidence to support the molecular basis for transmissible spongiform encephalopathy risk assessment.
Gale P
J Appl Microbiol; 2007 Dec; 103(6):2033-45. PubMed ID: 18045387
[TBL] [Abstract][Full Text] [Related]
30. A sensitive and quantitative assay for normal PrP in plasma.
Gregori L; Gray BN; Rose E; Spinner DS; Kascsak RJ; Rohwer RG
J Virol Methods; 2008 May; 149(2):251-9. PubMed ID: 18339433
[TBL] [Abstract][Full Text] [Related]
31. Prion removal capacity of plasma protein manufacturing processes: a data collection from PPTA member companies.
Cai K; Gröner A; Dichtelmüller HO; Fabbrizzi F; Flechsig E; Gajardo R; von Hoegen I; Jorquera JI; Kempf C; Kreil TR; Lee DC; Moscardini M; Pölsler G; Roth NJ
Transfusion; 2013 Sep; 53(9):1894-905. PubMed ID: 23252676
[TBL] [Abstract][Full Text] [Related]
32. Current strategies to prevent transmission of prions by human plasma derivatives.
Burnouf T; Padilla A
Transfus Clin Biol; 2006 Nov; 13(5):320-8. PubMed ID: 17254822
[TBL] [Abstract][Full Text] [Related]
33. Monitoring plasma processing steps with a sensitive Western blot assay for the detection of the prion protein.
Lee DC; Stenland CJ; Hartwell RC; Ford EK; Cai K; Miller JL; Gilligan KJ; Rubenstein R; Fournel M; Petteway SR
J Virol Methods; 2000 Jan; 84(1):77-89. PubMed ID: 10644089
[TBL] [Abstract][Full Text] [Related]
34. An improved Western blot assay to assess the clearance of prion protein from plasma-derived therapeutic proteins.
Hartwell RC; Nelson MS; Kislan MM; Stenland CJ; Miller JL; Pifat DY; Petteway SR; Cai K
J Virol Methods; 2005 May; 125(2):187-93. PubMed ID: 15794989
[TBL] [Abstract][Full Text] [Related]
35. Does an ultra violet photooxidation of the manganese-loaded/copper-depleted prion protein in the retina initiate the pathogenesis of TSE?
Purdey M
Med Hypotheses; 2001 Jul; 57(1):29-45. PubMed ID: 11421622
[TBL] [Abstract][Full Text] [Related]
36. Metal microcrystal pollutants: the heat resistant, transmissible nucleating agents that initiate the pathogenesis of TSEs?
Purdey M
Med Hypotheses; 2005; 65(3):448-77. PubMed ID: 15908137
[TBL] [Abstract][Full Text] [Related]
37. Consensus statement on the bio-safety of urinary-derived gonadotrophins with respect to Creutzfeldt-Jakob disease.
Balen AH; Lumholtz IB
Hum Reprod; 2005 Nov; 20(11):2994-9. PubMed ID: 16055457
[TBL] [Abstract][Full Text] [Related]
38. Pathogen Safety of a New Intravenous Immune Globulin 10% Liquid.
Radomski KU; Lattner G; Schmidt T; Römisch J
BioDrugs; 2017 Apr; 31(2):125-134. PubMed ID: 28236170
[TBL] [Abstract][Full Text] [Related]
39. A 25 nm virion is the likely cause of transmissible spongiform encephalopathies.
Manuelidis L
J Cell Biochem; 2007 Mar; 100(4):897-915. PubMed ID: 17044041
[TBL] [Abstract][Full Text] [Related]
40. Molecular assessment of the potential transmissibilities of BSE and scrapie to humans.
Raymond GJ; Hope J; Kocisko DA; Priola SA; Raymond LD; Bossers A; Ironside J; Will RG; Chen SG; Petersen RB; Gambetti P; Rubenstein R; Smits MA; Lansbury PT; Caughey B
Nature; 1997 Jul; 388(6639):285-8. PubMed ID: 9230438
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
